Freeman A P, Fatches K R, Carter I W, Cloonan M J, Wilcken D E
Br Heart J. 1981 Apr;45(4):389-92. doi: 10.1136/hrt.45.4.389.
We compared the clinical usefulness of serum myoglobin and creatine kinase MB (CK MB) isoenzyme determinations in the early diagnosis of acute myocardial infarction in 109 consecutive patients admitted to a coronary care unit. Of these, 37 patients were diagnosed as having definite infarction, three possible infarction, and 69 no infarction, using World Heath Organisation criteria. Blood samples were taken on admission and two to four hours later, Both CK MB and myoglobin were raised in the initial serum samples in 24 of the 37 patients with definite infarction. In an additional seven patients both CK MB and myoglobin were negative in the first specimen though both were detected in the second sample. In five patients CK MB preceded the appearance of myoglobin while in the remaining patient myoglobin appeared before CK MB. We conclude that the detection of serum myoglobin does not offer any clinical advantage over CK MG as an early indicator of myocardial infarction.
我们比较了血清肌红蛋白和肌酸激酶MB(CK MB)同工酶测定在109例连续入住冠心病监护病房患者急性心肌梗死早期诊断中的临床实用性。根据世界卫生组织标准,其中37例患者被诊断为明确梗死,3例可能梗死,69例无梗死。入院时及入院后两到四小时采集血样。37例明确梗死患者中的24例,其初始血清样本中的CK MB和肌红蛋白均升高。另外7例患者的首个样本中CK MB和肌红蛋白均为阴性,但在第二个样本中均被检测到。5例患者中CK MB先于肌红蛋白出现,而在其余患者中肌红蛋白先于CK MB出现。我们得出结论,作为心肌梗死的早期指标,血清肌红蛋白的检测在临床方面并不比CK MB更具优势。